In the Italian digital landscape, a figure is emerging that is increasingly relevant yet still lacking a clear regulatory framework: the sports trader, an operator who applies financial trading logic and tools to sports betting markets.

On this topic, Antonella Terranova and Gaspare Roma provide an in-depth analysis published in ItaliaOggi, examining:

• the operational characteristics of sports trading and the role of betting exchange platforms
• the structural differences compared to financial trading, particularly from a regulatory standpoint
• the legal issues arising from the absence of a formal legal definition of this role
• the potential risks, including criminal liability, for those operating professionally on behalf of third parties

A contribution that highlights how technological evolution is outpacing the law, leaving grey areas that require targeted regulatory intervention.

Read the full article in italian.

Download the full article.

With Resolution No. 85/26/CONS, AGCOM defines the boundaries of communication on the prevention of pathological gambling, implementing Article 15 of Legislative Decree No. 41/2024.

On Spot and Web, an article by Ilaria Sgrilli and Antonella Terranova examines in depth the seven pillars of the new framework, set within a layered regulatory landscape.

For years, the Dignity Decree (Decree-Law No. 87/2018) imposed an almost total ban on advertising, sponsorships, and even indirect forms of communication.

With Legislative Decree No. 41/2024, however, the legislator has opened up a specific space for informational and awareness-raising campaigns. Within this context, the AGCOM Resolution sets out the criteria to distinguish between prevention communication and commercial promotion.

What are the new margins for maneuver, and what are the main critical issues for licensees during the implementation phase?

Read the full article in italian.

Download the full article.

ABS – Acciaierie Bertoli Safau, through its subsidiary Rott-Ferr, has acquired 100% of the share capital of R. Casini, a company active for over forty years in the collection, processing, and commercialization of ferrous and metallic materials, based in Feletto Umberto (UD).

The transaction is part of ABS’s strategy to strengthen its scrap supply chain, initiated in 2023, and enables the creation of the largest regional hub for scrap management, with a total capacity of approximately 200,000 tons per year. The deal aligns with the group’s vertical integration strategy and reflects the growing importance of ferrous scrap for the European steel industry, in a context shaped by evolving Italian and European regulations concerning exports and the control of secondary raw materials.

The sellers were assisted by Studio De Berti Jacchia, with a team led by partner Claudio Corba Colombo, together with managing associate Benedetta Mazzotti on corporate M&A matters, and Ferruccio di Lenardo on financial aspects.

In the article by Gaspare Roma, Antonella Terranova, and Adriano Garofalo, published on NT+ Diritto of Il Sole 24 Ore, a recent decision by the Italian Data Protection Authority (no. 113/2026) is analyzed. The case concerns a Foundation, a public-law entity, and a manager dismissed for just cause.

The case revolves around the publication, in the “Transparent Administration” section, of a resolution regarding the dismissal of the manager, including his personal data and freely accessible online.

Following the employee’s complaint, the Authority recognized the precedence of the right to privacy over administrative transparency, contrary to the Foundation’s position. The latter had justified the publication by invoking transparency obligations, the strategic role of the manager, and the fact that the news had already been disclosed, also noting that the data had later been redacted.

The case brings back to the forefront a crucial question: where does the obligation of transparency end, and where does the protection of privacy begin?

But what did the Data Protection Authority actually establish in this case?

 

 

Read the full article in italian.

Download the full article.

In the article by Marco Stillo published on InsurZine, the protections available to passengers in the event of flight cancellations are examined, an increasingly frequent phenomenon due to ongoing strikes and geopolitical tensions.

Regulation (EC) No. 261/2004 grants passengers the right to a ticket refund or an alternative flight, as well as assistance (meals, accommodation, transport) and, in some cases, financial compensation. It is also essential to keep all documentation relating to the trip and any expenses incurred.

Since airline refunds do not always cover all economic consequences, it may be useful to complement them with travel insurance, which can cover additional risks such as illness or cancellation for personal reasons.

In such cases, it is crucial to carefully read the insurance terms and act promptly, in order to effectively combine legal protection with insurance coverage.

 

Read the full article in italian.

Download the full article.

On AboutPharma, an article by David Maria Santoro and Federica Bortolotti, together with Leonardo Toso and Matilde Bissolo from the Department of Diagnostics and Public Health – Section of Legal Medicine at the University of Verona, examines the issue of investigating the causal link in adverse reactions to medicinal products.

The article clarifies that, in the civil law context, the assessment of causation must combine epidemiological data deriving from the circulation of the medicinal product with the findings of a rigorous clinical analysis of the specific individual case, conducted according to medico-legal standards, seeking a “preponderance of the evidence” rather than certainty “beyond any reasonable doubt.”

The analysis of recent case law confirms this methodological approach, showing that the mere temporal correlation between the intake of a medicinal product and the onset of an adverse reaction is not sufficient, in itself, to establish liability for compensation.

When can the causal link between a medicinal product and an adverse event be considered proven?

 

Download the full article.

De Berti Jacchia assisted, respectively, Egea New Energy S.p.A., a company of the Iren Group, and S.A.R. S.r.l., as sellers, and Biomethanbrown Cremona 1 S.p.A. (a company of the Andion Group), as purchaser, in the transfer of the entire share capital of Biometano Cella Dati S.r.l., owner of a biomethane plant located in the Municipality of Cella Dati with a capacity of 4.2 m³.

De Berti Jacchia assisted Andion with a team led by Marco Frazzica and Giuseppina Zoccali.